Incidence of arterial thrombosis after administration of NOACs and LMWH in TKA and THA .
This report has been verified
by one or more authors of the
original publication.
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty
Thromb Haemost. 2015 Jul 28;114(2):237-4411 randomized controlled trials with 31,319 patients undergoing total knee or hip replacement and receiving either low molecular weight heparin (LMWH) or non-vitamin K antagonist oral anticoagulants (NOACs) for venous thromboembolism prophylaxis were included in this meta-analysis. The analysis was conducted in order to assess the incidence of postoperative arterial thrombosis (AT) following administration of NOAC and LMWH. Findings indicated that in both knee and hip arthroplasty, LMWH and NOACs result in a similar risk of arterial thrombosis events, including acute myocardial infarction and ischemic stoke.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
